M3 reported 1QFY03/2023 results yesterday. Both revenue and OP beat consensus estimates and the company's core biz Medical Platform saw some recovery in earnings. However, the segment's growth prospec
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.